Recombinant Human Apolipoprotein A II protein (rFc Tag)
Species
Human
Purity
>90 %, SDS-PAGE
Tag
rFc Tag
Activity
not tested
Cat no : Eg3085
Validation Data Gallery
Product Information
Purity | >90 %, SDS-PAGE |
Endotoxin | <0.1 EU/μg protein, LAL method |
Activity |
Not tested |
Expression | HEK293-derived Human Apolipoprotein A II protein Ala19-Gln100 (Accession# P02652) with a rabbit IgG Fc tag at the C-terminus. |
GeneID | 336 |
Accession | P02652 |
PredictedSize | 35.3 kDa |
SDS-PAGE | 35-42 kDa, reducing (R) conditions |
Formulation | Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization. |
Reconstitution | Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water. |
Storage Conditions |
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
|
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature. |
Background
Apolipoprotein A2 (Apo-A2) is the second major protein of the HDL-C particles and comprises about 20% of the total HDL-C protein content. It is primarily synthesized by liver. The predicted MW of ApoA2 is 11 kDa, while the mature form is smaller (7-10 kDa) since the signal peptide was cleaved. In humans, most of circulating apoA2 exist as dimer. Five types of APOA2 dimer exist: homodimer apoA2-ATQ/ATQ, heterodimer apoA2-ATQ/AT, homodimer apoA2-AT/AT, apoA2-AT/A, and apoA2-A/A. ApoA2 isoforms are considered to be some of the most promising serum/plasma biomarkers for aiding the early detection of pancreatic cancer.
References:
1.Bandarian F. et al. (2016) Iranian biomedical journal. 20(2), 84-90. 2.Moradi M. et al. (2017) Clinical Nutrition. 30, 1e5. 3.Ding, X. et al. (2018) Exp anim tokyo. 67(2):105-115. 4.Kobayashi, T. et al. (2018) Biochem bioph res co. 497(3):903-907.